Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial Dr David Preiss, PhD, Suzanne M Lloyd, MSc, Prof Ian Ford, PhD, Prof John J McMurray, MD, Prof Rury R Holman, FRCP, Paul Welsh, PhD, Prof Miles Fisher, MD, Prof Chris J Packard, DSc, Prof Naveed Sattar, PhD The Lancet Diabetes & Endocrinology Volume 2, Issue 2, Pages 116-124 (February 2014) DOI: 10.1016/S2213-8587(13)70152-9 Copyright © 2014 Preiss et al. Open Access article distributed under the terms of CC BY Terms and Conditions
Figure 1 Trial profile The Lancet Diabetes & Endocrinology 2014 2, 116-124DOI: (10.1016/S2213-8587(13)70152-9) Copyright © 2014 Preiss et al. Open Access article distributed under the terms of CC BY Terms and Conditions
Figure 2 Progression in mean cIMT (A), carotid plaque score (B), and bodyweight (C) Error bars are 95% CIs. cIMT=carotid intima-media thickness. The Lancet Diabetes & Endocrinology 2014 2, 116-124DOI: (10.1016/S2213-8587(13)70152-9) Copyright © 2014 Preiss et al. Open Access article distributed under the terms of CC BY Terms and Conditions